The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most research has focused on developing peptide multi-agonists as most o...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Society of Lipid and Atherosclerosis
2023-09-01
|
| Серии: | Journal of Lipid and Atherosclerosis |
| Предметы: | |
| Online-ссылка: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.3.213&code=9992JLA&vmode=FULL |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|